HomeTRDA • NASDAQ
add
Entrada Therapeutics Inc
Previous close
$12.74
Day range
$12.41 - $13.07
Year range
$4.93 - $13.66
Market cap
482.00M USD
Avg Volume
215.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.30M | -96.53% |
Operating expense | 9.35M | -5.16% |
Net income | -39.16M | -3,562.78% |
Net profit margin | -3.01K | -99,932.12% |
Earnings per share | -0.94 | -3,233.33% |
EBITDA | -39.42M | -708.66% |
Effective tax rate | -0.24% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 295.70M | -29.60% |
Total assets | 377.38M | -28.30% |
Total liabilities | 71.24M | -27.04% |
Total equity | 306.13M | — |
Shares outstanding | 36.00M | — |
Price to book | 1.50 | — |
Return on assets | -25.50% | — |
Return on capital | -26.87% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -39.16M | -3,562.78% |
Cash from operations | -32.20M | -1.89% |
Cash from investing | 29.12M | -45.43% |
Cash from financing | 192.00K | -86.31% |
Net change in cash | -2.89M | -112.49% |
Free cash flow | -18.23M | 45.74% |
About
Founded
2016
Headquarters
Website
Employees
152
